Annual EBITDA
$3.26B$400.00M+13.97%
Summary
- Current Value
- As of today, CAH annual EBITDA is $3.26B, up +13.97% on
- Historical Performance
- CAH annual EBITDA is up +36.19% over the past 3 years, and up +20.94% over the past 5 years
- All-Time High Comparison
- CAH annual EBITDA is currently -8.24% below its historical high of $3.56B set on
- 3-Year Low Comparison
- CAH annual EBITDA is +36.19% above its 3-year low of $2.40B reached on an earlier date
- Sector Comparison
- CAH annual EBITDA is higher than 97.76% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.26B | +14.0% | +36.2% | +20.9% | +100.7% | |
| Quarterly EBITDA | $1.04B | +37.6% | +82.7% | +45.9% | +121.7% | |
| TTM EBITDA | $3.91B | +30.7% | +70.9% | +42.1% | +122.1% | |
| Price | $226.32 | +78.1% | +193.8% | +317.1% | +440.7% | |
| PE Ratio | 32.57 | +37.7% | – | +181.5% | +108.5% | |
| Annual Revenue | $222.58B | -1.9% | +22.7% | +45.5% | +126.0% | |
| Annual EPS | $6.45 | +87.0% | +292.9% | +151.1% | +263.0% | |
| $2.79B | +29.4% | +66.5% | +56.4% | +101.7% | ||
| Annual Net Income | $1.57B | +83.9% | +268.4% | +142.5% | +167.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.26B | at high | |
| 5Y | $3.26B | at high | |
| All | $3.56B | -8.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.40B | N/A | +36.2% |
| 5Y | $2.40B | +36.2% | |
| All | $4.10M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of CAH?
As of today, CAH annual EBITDA is $3.26B
What is 1-year change in CAH annual EBITDA?
CAH annual EBITDA is up +13.97% year-over-year
What is 3-year change in CAH annual EBITDA?
CAH annual EBITDA is up +36.19% over the past 3 years
How far is CAH annual EBITDA from its all-time high?
CAH annual EBITDA is currently -8.24% below its historical high of $3.56B set on June 30, 2018
How does CAH annual EBITDA rank versus sector peers?
CAH annual EBITDA is higher than 97.76% of companies in Healthcare sector
When is CAH next annual earnings release?
As of today, the next annual earnings release for CAH has not been scheduled
Quarterly EBITDA
$1.04B$39.00M+3.88%
Summary
- Current Value
- As of today, CAH quarterly EBITDA is $1.04B, up +3.88% on
- Historical Performance
- CAH quarterly EBITDA is up +37.60% year-over-year, and up +82.66% over the past 3 years
- All-Time High Comparison
- CAH quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH quarterly EBITDA is +82.66% above its 3-year low of $571.00M reached on an earlier date
- Sector Comparison
- CAH quarterly EBITDA is higher than 98.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.04B | +3.9% | +37.6% | +82.7% | +45.9% | |
| Annual EBITDA | $3.26B | – | +14.0% | +36.2% | +20.9% | |
| TTM EBITDA | $3.91B | +7.9% | +30.7% | +70.9% | +42.1% | |
| Price | $226.32 | +14.3% | +78.1% | +193.8% | +317.1% | |
| PE Ratio | 32.57 | +9.0% | +37.7% | – | +181.5% | |
| Quarterly Revenue | $65.63B | +2.5% | +18.8% | +27.5% | +58.0% | |
| Quarterly EPS | $1.97 | +4.7% | +19.7% | +495.6% | -7.6% | |
| $809.00M | +4.9% | +42.9% | +101.8% | +56.8% | ||
| Quarterly Net Income | $471.00M | +3.7% | +17.5% | +462.3% | -25.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.04B | at high | |
| 3Y | $1.04B | at high | |
| 5Y | $1.04B | at high | |
| All | $1.04B | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $758.00M | N/A | +37.6% |
| 3Y | $571.00M | N/A | +82.7% |
| 5Y | $435.00M | +139.8% | |
| All | -$484.00M | +315.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CAH?
As of today, CAH quarterly EBITDA is $1.04B
What is CAH quarterly EBITDA most recent change?
CAH quarterly EBITDA was up +3.88% on December 31, 2025
What is 1-year change in CAH quarterly EBITDA?
CAH quarterly EBITDA is up +37.60% year-over-year
How far is CAH quarterly EBITDA from its all-time high?
CAH quarterly EBITDA is currently at its all-time high
How does CAH quarterly EBITDA rank versus sector peers?
CAH quarterly EBITDA is higher than 98.07% of companies in Healthcare sector
When is CAH next earnings release?
The next earnings release for CAH is on
TTM EBITDA
$3.91B$285.00M+7.86%
Summary
- Current Value
- As of today, CAH TTM EBITDA is $3.91B, up +7.86% on
- Historical Performance
- CAH TTM EBITDA is up +30.66% year-over-year, and up +70.90% over the past 3 years
- All-Time High Comparison
- CAH TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH TTM EBITDA is +70.90% above its 3-year low of $2.29B reached on an earlier date
- Sector Comparison
- CAH TTM EBITDA is higher than 97.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.91B | +7.9% | +30.7% | +70.9% | +42.1% | |
| Annual EBITDA | $3.26B | – | +14.0% | +36.2% | +20.9% | |
| Quarterly EBITDA | $1.04B | +3.9% | +37.6% | +82.7% | +45.9% | |
| Price | $226.32 | +14.3% | +78.1% | +193.8% | +317.1% | |
| PE Ratio | 32.57 | +9.0% | +37.7% | – | +181.5% | |
| TTM Revenue | $244.67B | +4.4% | +10.1% | +26.8% | +56.4% | |
| TTM EPS | $6.95 | +4.9% | +29.4% | +249.4% | +48.1% | |
| $3.03B | +8.7% | +34.2% | +90.7% | +59.8% | ||
| TTM Net Income | $1.68B | +4.4% | +27.6% | +231.8% | +21.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.91B | at high | |
| 3Y | $3.91B | at high | |
| 5Y | $3.91B | at high | |
| All | $3.91B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.99B | N/A | +30.7% |
| 3Y | $2.29B | N/A | +70.9% |
| 5Y | $2.27B | +72.5% | |
| All | -$96.20M | +4166.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CAH?
As of today, CAH TTM EBITDA is $3.91B
What is CAH TTM EBITDA most recent change?
CAH TTM EBITDA was up +7.86% on December 31, 2025
What is 1-year change in CAH TTM EBITDA?
CAH TTM EBITDA is up +30.66% year-over-year
How far is CAH TTM EBITDA from its all-time high?
CAH TTM EBITDA is currently at its all-time high
How does CAH TTM EBITDA rank versus sector peers?
CAH TTM EBITDA is higher than 97.88% of companies in Healthcare sector
When is CAH next earnings release?
The next earnings release for CAH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CAH Official Website www.cardinalhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/721371/000072137126000006/0000721371-26-000006-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/721371/000072137125000079/0000721371-25-000079-index.htm
- CAH Profile on Yahoo Finance finance.yahoo.com/quote/CAH
- CAH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cah